UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy

The Journal of pathology, 2012-04, Vol.226 (5), p.796-805

2012

Volltextzugriff (PDF)

CD99 at the crossroads of physiology and pathology

Journal of cell communication and signaling, 2018-03, Vol.12 (1), p.55-68

2018

Volltextzugriff (PDF)

Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations

Scientific reports, 2019-08, Vol.9 (1), p.12174-12, Article 12174

2019

Volltextzugriff (PDF)

miRNA expression profile in human osteosarcoma: Role of miR-1 and miR-133b in proliferation and cell cycle control

International journal of oncology, 2013-02, Vol.42 (2), p.667-675

2013

Volltextzugriff (PDF)

ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity

Journal of experimental & clinical cancer research, 2019-12, Vol.38 (1), p.503-503, Article 503

2019

Volltextzugriff (PDF)

Inhibition of Insulin-like Growth Factor I Receptor Increases the Antitumor Activity of Doxorubicin and Vincristine against Ewing’s Sarcoma Cells

Clinical cancer research, 2001-06, Vol.7 (6), p.1790-1797

2001

Volltextzugriff (PDF)

Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma

Cancers, 2023-07, Vol.15 (15), p.3887

2023

Volltextzugriff (PDF)

Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma

Cells (Basel, Switzerland), 2021-02, Vol.10 (2), p.416

2021

Volltextzugriff (PDF)

A 3D Collagen-Based Bioprinted Model to Study Osteosarcoma Invasiveness and Drug Response

Polymers, 2022-09, Vol.14 (19), p.4070

2022

Volltextzugriff (PDF)

Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma

Cell death & disease, 2022-04, Vol.13 (4), p.346-346, Article 346

2022

Volltextzugriff (PDF)

Targeting ROCK2 rather than ROCK1 inhibits Ewing sarcoma malignancy

Oncology reports, 2017-03, Vol.37 (3), p.1387-1393

2017

Volltextzugriff (PDF)

CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis

The Journal of clinical investigation, 2010-03, Vol.120 (3), p.668-680

2010

Volltextzugriff (PDF)

Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Modulates Aggressiveness of Ewing Sarcoma by Regulating the CD164-CXCR4 Axis

Frontiers in oncology, 2020-07, Vol.10, p.994-994

2020

Volltextzugriff (PDF)

Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug

PloS one, 2013-12, Vol.8 (12), p.e83832-e83832

2013

Volltextzugriff (PDF)

IL-1 Family Members in Bone Sarcomas

Cells (Basel, Switzerland), 2024-01, Vol.13 (3), p.233

2024

Volltextzugriff (PDF)

Overcoming Resistance to Conventional Drugs in Ewing Sarcoma and Identification of Molecular Predictors of Outcome

Journal of clinical oncology, 2009-05, Vol.27 (13), p.2209-2216

2009

Volltextzugriff (PDF)

Impact of ABC Transporters in Osteosarcoma and Ewing’s Sarcoma: Which Are Involved in Chemoresistance and Which Are Not?

Cells (Basel, Switzerland), 2021-09, Vol.10 (9), p.2461

2021

Volltextzugriff (PDF)

Novel Targeting of DNA Methyltransferase Activity Inhibits Ewing Sarcoma Cell Proliferation and Enhances Tumor Cell Sensitivity to DNA Damaging Drugs by Activating the DNA Damage Response

Frontiers in endocrinology (Lausanne), 2022-05, Vol.13, p.876602-876602

2022

Volltextzugriff (PDF)

Identification of Common and Distinctive Mechanisms of Resistance to Different Anti-IGF-IR Agents in Ewing's Sarcoma

Molecular endocrinology (Baltimore, Md.), 2012-09, Vol.26 (9), p.1603-1616

2012

Volltextzugriff (PDF)

Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors

Cancer research (Chicago, Ill.), 2005-05, Vol.65 (9), p.3868-3876

2005

Volltextzugriff (PDF)

Expression of insulin-like growth factor system components in Ewing’s sarcoma and their association with survival

European journal of cancer (1990), 2011-05, Vol.47 (8), p.1258-1266

2011

Volltextzugriff (PDF)

Characterization of human mesenchymal stem cells from ewing sarcoma patients. Pathogenetic implications

PloS one, 2014-02, Vol.9 (2), p.e85814-e85814

2014

Volltextzugriff (PDF)

Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of IGF1R

Frontiers in endocrinology (Lausanne), 2018-04, Vol.9, p.178-178

2018

Volltextzugriff (PDF)

Designing novel therapies against sarcomas in the era of personalized medicine and economic crisis

Current pharmaceutical design, 2013, Vol.19 (30), p.5344-5361

2013

Volltextzugriff (PDF)

1 – 25 von 123

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(115)

Publikationsform

Artikel
(123)

Sprache

Englisch
(122)
Japanisch
(25)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy

CD99 at the crossroads of physiology and pathology

Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations

miRNA expression profile in human osteosarcoma: Role of miR-1 and miR-133b in proliferation and cell cycle control

ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity

Inhibition of Insulin-like Growth Factor I Receptor Increases the Antitumor Activity of Doxorubicin and Vincristine against Ewing’s Sarcoma Cells

Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma

Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma

A 3D Collagen-Based Bioprinted Model to Study Osteosarcoma Invasiveness and Drug Response

Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma

Targeting ROCK2 rather than ROCK1 inhibits Ewing sarcoma malignancy

CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis

Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Modulates Aggressiveness of Ewing Sarcoma by Regulating the CD164-CXCR4 Axis

Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug

IL-1 Family Members in Bone Sarcomas

Overcoming Resistance to Conventional Drugs in Ewing Sarcoma and Identification of Molecular Predictors of Outcome

Impact of ABC Transporters in Osteosarcoma and Ewing’s Sarcoma: Which Are Involved in Chemoresistance and Which Are Not?

Novel Targeting of DNA Methyltransferase Activity Inhibits Ewing Sarcoma Cell Proliferation and Enhances Tumor Cell Sensitivity to DNA Damaging Drugs by Activating the DNA Damage Response

Identification of Common and Distinctive Mechanisms of Resistance to Different Anti-IGF-IR Agents in Ewing's Sarcoma

Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors

Bone Turnover Marker (BTM) Changes after Denosumab in Giant Cell Tumors of Bone (GCTB): A Phase II Trial Correlative Study

Expression of insulin-like growth factor system components in Ewing’s sarcoma and their association with survival

Characterization of human mesenchymal stem cells from ewing sarcoma patients. Pathogenetic implications

Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Influences Sensitivity to Anti-IGF System Agents Through the Translational Regulation of IGF1R

Designing novel therapies against sarcomas in the era of personalized medicine and economic crisis

Suchergebnisse filtern